Skip to main content
Journal of Atrial Fibrillation logoLink to Journal of Atrial Fibrillation
. 2012 Oct 6;5(3):559. doi: 10.4022/jafib.559

Predictors of Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation

Miki Yokokawa 1,*, Hakan Oral 1, Aman Chugh 1
PMCID: PMC5153209  PMID: 28496769

Abstract

Radiofrequency catheter ablation that targets the pulmonary veins is well established as a mainstay for drug-refractory, paroxysmal atrial fibrillation (AF). However, in patients with persistent AF, the ideal approach remains elusive. Further, despite the various additional ablation strategies that have been investigated in patients with persistent AF, the rate of recurrent atrial tachyarrhythmias after ablation remains relatively high. In this review, the predictors of recurrent atrial tachyarrhythmias after catheter ablation of persistent AF will be discussed.

Introduction

While there is consensus regarding the ablation strategy in patients with paroxysmal atrial fibrillation (AF),[1] the ideal strategy for patients with persistent AF remains unclear. Patients with persistent AF do not respond well to pulmonary vein (PV) isolation as the sole strategy.[2] Although outcome in patients with persistent AF is improved with extra-PV ablation, e.g., ablation of complex fractionated atrial electrograms (CFAEs) and linear ablation, patients frequently require repeat ablation procedures for organized arrhythmias.[3] Identifying the predictors of recurrence is of obvious clinical importance in enhancing efficacy and achieving better long-term outcomes. This review focuses on predictors of recurrent atrial tachyarrhythmias after ablation of persistent AF.

Predictors of Recurrent Atrial Arrhythmias

Several studies have reported various factors as predictive of arrhythmia recurrence. These include demographic factors such as age[4,5] and duration of AF,[6] and comorbid conditions such as metabolic syndrome[7] and obstructive sleep apnea.[8] The impact of coexisting heart diseases may also contribute to AF recurrence.[9] Apart from demographic and historical factors, structural remodeling as revealed by imaging modalities such as echocardiography,[10] computed tomography,[11,12] and magnetic resonance imaging[13,14] have also been shown to be associated with arrhythmia outcome. Invasively determined factors such as AF cycle length,[1516] atrial pressure,[17] and volume18 have also been evaluated. More sophisticated techniques such as substrate mapping,[19] AF frequency,[20] and integrity of linear lesions[21,22] have also shown to be important in predicting arrhythmia recurrence after catheter ablation. These factors will be each discussed in detail below.

Patients Characteristics

Age

Advancing age is a strong risk factor for the development of AF and is associated with arrhythmia recurrence following catheter ablation of persistent AF.[4,5] Aging is related to structural remodeling culminating in low voltage areas/scar and conduction slowing associated with atrial fibrosis.[2326] Atrial fibrosis may increase the complexity of the fibrillatory process by causing formation of multiple drivers.[27] In fact, advancing age was the only predictor of left atrial (LA) scarring in a recent study.[28]In the absence of randomized data or observational data from large studies, it is not clear whether the elderly fare worse with catheter ablation as compared to younger cohorts. Prior studies have reported that outcomes in the elderly are not significantly different than in younger patients.[29,30] More recent studies have reported discordant results. For example, a study by Yoshida et al. concluded that age is associated with recurrence in patients undergoing an extensive ablation strategy for persistent AF.[5] In a more recent study, it was shown that the efficacy and complication rates are in keeping with those of younger patients.[28] It is probably fair to conclude that arrhythmogenic substrate in the elderly is likely to be more complex that in younger patients, and elderly patients with significant structural remodeling probably do not respond as well to catheter ablation. However, patients should not be excluded from undergoing ablation on the basis of age alone.[31]

Duration of AF

Longer duration of AF is associated with shortening of the atrial effective refractory period, which further perpetuates AF.[6] The perpetuation of AF itself contributes to electric and structural remodeling of the atria. Patients with longer durationof persistent AF do not respond as well to antiarrhythmic medications, catheter or surgical ablation,[32] and are more likely to have recurrence of atrial arrhythmias after the ablation.[3334] A recent study suggested that the distribution of the atrial substrate differs among patients depending on the duration of AF.[33] In patients with long-standing AF, the fibrillatory substrate includes not only the left but also the right atrium (Figure 1). These patients not only require additional ablation during the index procedure, but may also require repeat ablation procedures after elimination of the LA contribution. The potential targets in the right atrium include the right atrial appendage, free wall along the tricuspid annulus, the septum, roof of the right atrium, ostium of the coronary sinus, and the posterior wall.[35] Identification of complex electrograms at these candidate sites is key to eliminate right atrial drivers in these patients.

Figure 1. Additional ablation of complex fractionated atrial electrograms at the base of the right atrial appendage (A) resulted in termination of atrial fibrillation (AF) to sinus rhythm during ablation in a patient with long-standing persistent AF (B). ABL= ablation catheter; CS= coronary sinus; IVC= inferior vena cava; LA= left atrium; RA= right atrium; SVC= superior vena cava .

Figure 1.

Structural Heart Disease

The presence of structural heart disease such as valvular heart disease,[3637] nonischemic cardiomyopathy,[36] hypertrophic cardiomyopathy[38] and coronary disease[39] is likely associated with higher recurrence rates after AF ablation. Patients with valvular heart disease may have a higher degree of atrial disarray and irreversible fibrosis which curtail the successful outcome after the ablation. The advanced valvular disease could develop irreversible atrial myopathy. AF recurrence of hypertrophic cardiomyopathy often accompany with diastolic dysfunction, elevated LA pressure, and LA enlargement. The progressive atrial remodeling, fibrosis by collagen metabolism abnormalities, atrial stretch and enlargement exacerbated by rising left ventricular filling pressure could have contributed substantially to AF recurrence in patients with structural heart disease, even when the procedure is initially successful. The challenges in these patients include not only the severely enlarged atria, but also the presence of atrial scarring. These findings should be taken into consideration when selecting patients for ablation of persistent AF.

Metabolic Syndromep

Metabolic syndrome defined as obesity, hypertension, dyslipidemia, diabetes and glucose intolerance is associated with a larger LA size and may increase the risk for recurrence after AF ablation.[7] Hypertension is associated with diastolic ventricular dysfunction, left ventricular hypertrophy and elevated intracardiac pressure.[40] Obesity is associated with impaired ventricular diastolic performance and may promotes atrial remodeling due to the chronic elevation in the intracardiac pressures.[41] In obese patients, elevated plasma volume, enhanced neurohormonal activation along with oxidative stress and subclinical inflammation conditions may play a role in the perpetuation of AF.[42] A recent study demonstrated that baseline inflammatory markers such as C-reactive protein and total white blood cell count are associated with metabolic syndrome predicted higher recurrence rate after AF ablation.[43] Although patients with metabolic syndrome may be more likely to experience arrhythmia recurrence, these patients should not be denied catheter ablation based on this factor alone. These patients may be more likely to require repeat procedures and perhaps, an extra-PV approach, but the expectation is that the majority of these patients with drug-refractory AF should benefit from catheter ablation.

Obstructive Sleep Apnea

Obstructive sleep apnea is associated with an increase in the probability of AF recurrence after ablation.[8] Possible mechanisms by which obstructive sleep apnea predisposes to AF include intermittent hypoxemia, hypercapnia, autonomic imbalance with surges in sympathetic tone. Hypoxemia and hypercapnia have direct adverse effects on cardiac electrical stability. The sympathetically mediated vasoconstriction increases arterial pressure andcause diastolic dysfunction followed by LA dilatation. Atrial stretch also may promote emergence of new triggers and perpetuate AF. Recent study demonstrated that treatment of continuous positive airway pressure improved success rate of AF ablation in patients with obstructive sleep apnea.[44] Continuous positive airway pressure may decrease frequency of hypoxemic episodes, prevent atrial stretch and raise the nadir value for lower nocturnal oxygen saturation.

Atrial Remodeling

LA Size

LA size is a predictor of freedom from atrial arrhythmias after single and repeat ablation procedures.[10] Remodeling of the atria during persistent AF is a time-dependent process, and typically results in the enlargement of LA dimensions.[5] Atrial dilatation has been recognized as a major pathophysiological factor in the perpetuation of AF.[45] An enlarged atrium modulates the electroanatomic substrate with the increased nonuniform anisotropy and a conduction disturbance, which could contribute to the heterogeneity of the LA. A prior experimental study showed that atrial stretch resulted from LA dilatation also may promote AF maintenance by high-frequency focal discharges that generate fibrillatory conduction and wave break.[46]

LA diameter measured from the parasternal long-axis view on transthoracic echocardiography, has been widely used to assess the LA size. However, recent studies have suggested that LA volume may be more accurate in the estimation of the LA size and may be a more robust marker of recurrrence.[18] Patients with severe LA enlargement (>5.5 cm on transthoracic echocardiography) should be counseled that they are probably more likely to require multiple procedures prior to achieving sinus rhythm. These patients may harbor AF drivers that are not addressed by PV isolation or ablation of complex electrograms. Further, in patients with severe chamber dilatation, technical issues such as catheter stability may also play a role in arrhythmia recurrence. Lastly, the processes (other than AF) that contribute to chamber enlargement, e.g., hypertension, sleep apnea, heart failure, and others need to be constantly addressed to prevent further adverse remodeling. Patients with an LAdiameter >6.5 cm probably should not be offered catheter ablation since their outcomes are likely to be suboptimal despite multiple procedures of long duration.

Atrial Pressure

The atrial stretch imparted by elevated LA pressure may contribute to the maintenance of AF by stabilizing high-frequency sources and make it less likely to spontaneous terminate.[17] The higher LA pressure in patients with persistent AF results in a greater degree of stretch-related electrical remodeling, resulting in a higher AF frequency.[17] A stretch-related mechanisms of AF has been proposed in a number of clinical conditions, such as mitral valve disease, heart failure and obstructive sleep apnea. Treatment of the underlying conditions, such as hypertension, sleep apnea, heart failure, and obesity may be protective in preventing ongoing structural remodeling related to atrial stretch.

Preexistent LA Scarring

Fibrosis in the LA may help to anchor reentrant circuits, alter the wave-front propergation and cause wave break and conduction delay.[7] Patients with LA scar were less likely to respond to catheter ablation.[13,14] Recently, delayed enhanced magnetic resonance imaging using gadolinium contrast has been used to analyze scar burden.[13,14] The LA voltage during catheter mapping may be representative of the structural integrity of the atria and a lower voltage is a predictor of recurrent atrial tachyarrhythmias after AF ablation.[19] The posterior wall is preferentially scarred in patients with persistent AF.[13] The posterior LA scarring could be associated with a lower contribution of PV arrhythmogenicity, making antral PV isolation less likely to be effective. These patients obviously require mapping of AF drivers outside the PV antrum. Possible strategies include linear ablation and ablation of CFAEs.

Procedural Parameters

AF Cycle Length

AF cycle length may be used as a surrogate parameter for the acute efficacy of ablation.[4749] A shorter AF cycle length reflects a short refractory period and higher number of perpetuating activities, both of which are characteristic of persistent AF.[47] AF termination is more likely to occur in patients with a longer AF cycle length at baseline.[43] However, this may not be the case in patients with LA scar.[28] Although the baseline AF cycle length is longer in patients with scar, this does not necessarily make it easier to terminate AF with the ablation. It is possible that AF cycle length is not a reliable marker of acute efficacy of ablation in patients with LA scar.[28] A recent study using fast Fourier transform analysis demonstrated that a reduction in the dominant frequency by 11% or more by the ablation was a predictor of successful outcome with less radiofrequency energy and a shorter procedure time than those of termination of AF.[20] Whether tailoring the ablation procedure with respect to real time frequency analysis is associated with an improved outcome is unknown.

PV Reconnection

Although the clinical efficacy of pulmonary vein isolation is much lower when AF is persistent than when it is paroxysmal, PV isolation is the cornerstone of AF ablation.[51] A recent study reported that in patients who underwent repeat ablation for arrhythmia recurrences after ablation of persistent AF, more than 1 PVs reconnected in all patients and only re-isolating these PVs resulted in no recurrence in 80% of patients.[52] The preprocedural recognition of specific patterns and variants of PV anatomy may be helpful as a roadmap to help achieve PV isolation. Computed tomography and magnetic resonance imaging acquired before the ablation provide detailed anatomic features and morphological changes. Anatomical variations of the PVs may be detected in up to 30% of patients and the most frequent variant is the common ostium of the left-sided PVs.[53] Since a common ostium usually is larger than the diameter of available circular mapping catheters, precise mapping and localization of PV fascicles may be challenging. Further studies are needed to clarify the clinical utility of preprocedural imaging to detect specific patterns and variants of PV anatomy. Recently, cryoablation has emerged as a promising tool allowing PV isolation in a safe and effective manner. However, in some patients, electrical isolation of all PVs cannot be achieved using a single size cryoballoon because of unfavorable angulations of the PV ostia and the size of the PV ostia relative to the ablation catheter.[54]

Ablation of CFAE as a Risk Factor for AT

CFAEs may indicate sites of slow conduction, collision, anchor points for reentrant circuits, wavebreak and fibrillatory conduction at the periphery of a rotor.[5557] Although ablation of CFAEs has been reported to achieve long-term arrhythmia freedom after a single procedure in up to 70% of patients with persistent AF,[56] there has been difficulty reproducing these results using CFAE ablation alone.[57] The potential explanations for the discrepancy were the inconsistency in interpretation of CFAEs, inadequate CFAE ablation and proarrhythmic effect of CFAE ablation by creating zones of slow conduction.[58] A prior study suggested that extensive ablation creates extremely slow conduction that allows for small circuits.[59] The localized reentrant atrial tachycardias were found predominantly within regions in which CFAEs were ablated. However, CFAEs remain an important target in patients undergoing catheter ablation of persistent AF.[60]

Linear Block

Linear ablation of the LA roof and the mitral isthmus have a role in elimination of AF following PV isolation.[6162] Linear ablation has been demonstrated to be necessary to terminate AF in large percentage of patients with long-standing persistent AF in a prior study.[48] Documentation of conduction block across these lines is critical and has been shown to be associated with a lower risk of recurrent atrial tachycardias. Indeed, incomplete mitral isthmus or roof lines may serve as a significant substrate for gap-related proarrhythmia (Figure 2).[2122]

Figure 2. Activation map during peri-mitral reentry (A: left anterior oblique projection). Entrainment mapping from the lateral mitral annulus demonstrates that the post-pacing interval is 245 ms, matching the tachycardia cycle length (B). Endocardial ablation at the mitral isthmus failed to terminate the tachycardia. Radiofrequency energy delivery in the distal coronary sinus (CS) terminated the tachycardia to sinus rhythm. (C). ABL= ablation catheter; MA= mitral annulus.

Figure 2.

A previous study demonstrated that the morphological characteristics of the mitral isthmus and its anatomical relationship to the adjacent vasculature affect the achieving conduction block.[12] A pouch morphology, greater isthmus depth, and the circumflex artery are associated with challenging linear ablation at the mitral isthmus. An interposed circumflex artery is also predictive of unsuccessful linear ablation at the mitral isthmus. The heat-sink effect of blood flow in the circumflex artery may prevent adequate heating of the atrial myocardium during ablation. If an interposed circumflex artery is found on computed tomography or magnetic resonance imaging, it is probably best to avoid empiric ablation at the mitral isthmus in patients with persistent AF. In patients with a pouch morphology, it may be difficult to achieve adequate tissue contact during endocardial ablation and hence, very frequently require ablation within the coronary sinus to achieve complete block.

Conduction block of the LA roof was reached more frequently compared with the mitral isthmus.[62] However, it may be challenging in some patients. Several studies have analyzed the anatomy of the LA roof in patients undergoing AF ablation.[1163] A recent study suggested that there was no significant difference in the myocardial thickness of the LA roof, curvilinear length, distance to the right pulmonary artery, angulation with respect to the superior pulmonary veins, or other morphological aspects of the LA roof in patients with and without complete block.[64] A left (from the circumflex artery) sinus node artery was the only independent predictor of incomplete conduction block at the LA roof.[64] The left sinus node artery may act as an epicardial heat-sink, preventing adequate heating of the LA roof during linear ablation.

Termination of AF during Catheter Ablation

Termination of persistent AF during ablation usually requires extensive ablation beyond the PVs, including ablation of CFAEs and multiple linear lesions. Termination of AF may represent suppression of AF drivers and perpetuating activities and has been associated with good outcomes.[4749]However, recent studies suggested that AF termination did not impact the long-term sinus rhythm maintenance.[5,65,66] After extensive ablation, patients may not longer have AF but instead may require repeat procedures for atrial tachycardias.[65]

We need to find out how much ablation is required to eliminate AF and to avoid excessive ablation which may be detrimental not only in terms of pro-arrhythmia but also LA mechanical function. To be sure, some patients require ablation of organized atrial tachycardias as an intermediate step before sinus rhythm is achieved. The challenge is to reduce the prevalence of atrial tachycardias while maintaining the efficacy of AF elimination.

Spectral Characteristics of AF

A recent study that analyzed the spectral characteristics of AF suggested that atrial tachycardias to which AF converts during the ablation may represent organized tachycardias that coexist with AF despite a lower frequency.[67] Those spectral components were more prevalent at baseline among patients in whom AF persisted than in those in whom AF terminated during ablation.[68] In addition, linear ablation resulted in a significant decrease in the prevalence of spectral components.[68] Whether the prevalence of spectral components can be used as a predictor of recurrent atrial tachyarrhythmias after ablation of persistent AF remains to be determined.

Early Recurrence of Atrial Tachyarrhythmias

Early recurrence of atrial tachyarrhythmias has typically not been equated with procedural failure. A transient increase in atrial vulnerability caused by an acute inflammatory changes due to radiofrequency energy and autonomic remodeling after ablation may cause early recurrences of atrial tachyarrhythmias.[69] A recent study suggested that transient use of corticosteroids shortly after AF ablation may inhibit inflammatory responses and decrease early AF recurrences.[70] Corticosteroid treatment may also halt electrical or functional remodeling and prevent late AF recurrences.[70] Early recurrence of atrial tachyarrhythmias has also been associated with late arrhythmia recurrences after ablation of persistent AF.[52,71] However, the mechanisms of early recurrence of atrial tachyarrhythmias needs further study and the optical timing for the second procedure needs to be defined.

Conclusions

Knowledge of the predictors of recurrent atrial tachyarrhythmias may play an important role to improve long-term outcome after catheter of persistent AF. Further studies are needed to clarify the clinical significance of these predictors in large cohorts of patients and identify the strategies to maintain sinus rhythm after the ablation in patients with persistent AF.

Disclosures

No disclosures relevant to this article were made by the authors.

References

  • 1.Haïssaguerre M, Jaïs P, Shah D C, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 1998 Sep 03;339 (10):659–66. doi: 10.1056/NEJM199809033391003. [DOI] [PubMed] [Google Scholar]
  • 2.Oral Hakan, Knight Bradley P, Tada Hiroshi, Ozaydin Mehmet, Chugh Aman, Hassan Sohail, Scharf Christoph, Lai Steve W K, Greenstein Radmira, Pelosi Frank, Strickberger S Adam, Morady Fred. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation. 2002 Mar 05;105 (9):1077–81. doi: 10.1161/hc0902.104712. [DOI] [PubMed] [Google Scholar]
  • 3.Cappato Riccardo, Calkins Hugh, Chen Shih-Ann, Davies Wyn, Iesaka Yoshito, Kalman Jonathan, Kim You-Ho, Klein George, Natale Andrea, Packer Douglas, Skanes Allan, Ambrogi Federico, Biganzoli Elia. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010 Feb;3 (1):32–8. doi: 10.1161/CIRCEP.109.859116. [DOI] [PubMed] [Google Scholar]
  • 4.Go A S, Hylek E M, Phillips K A, Chang Y, Henault L E, Selby J V, Singer D E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 09;285 (18):2370–5. doi: 10.1001/jama.285.18.2370. [DOI] [PubMed] [Google Scholar]
  • 5.Yoshida Kentaro, Rabbani Amir B, Oral Hakan, Bach David, Morady Fred, Chugh Aman. Left atrial volume and dominant frequency of atrial fibrillation in patients undergoing catheter ablation of persistent atrial fibrillation. J Interv Card Electrophysiol. 2011 Nov;32 (2):155–61. doi: 10.1007/s10840-011-9590-0. [DOI] [PubMed] [Google Scholar]
  • 6.Wijffels M C, Kirchhof C J, Dorland R, Allessie M A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995 Oct 01;92 (7):1954–68. doi: 10.1161/01.cir.92.7.1954. [DOI] [PubMed] [Google Scholar]
  • 7.Chang Shih-Lin, Tuan Ta-Chuan, Tai Ching-Tai, Lin Yenn-Jiang, Lo Li-Wei, Hu Yu-Feng, Tsao Hsuan-Ming, Chang Chien-Jun, Tsai Wen-Chin, Chen Shih-Ann. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am. J. Cardiol. 2009 Jan 01;103 (1):67–72. doi: 10.1016/j.amjcard.2008.08.042. [DOI] [PubMed] [Google Scholar]
  • 8.Jongnarangsin Krit, Chugh Aman, Good Eric, Mukerji Siddharth, Dey Sujoya, Crawford Thomas, Sarrazin Jean F, Kuhne Michael, Chalfoun Nagib, Wells Darryl, Boonyapisit Warangkna, Pelosi Frank, Bogun Frank, Morady Fred, Oral Hakan. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 2008 Jul;19 (7):668–72. doi: 10.1111/j.1540-8167.2008.01118.x. [DOI] [PubMed] [Google Scholar]
  • 9.Weerasooriya Rukshen, Khairy Paul, Litalien Jean, Macle Laurent, Hocini Meleze, Sacher Frederic, Lellouche Nicolas, Knecht Sebastien, Wright Matthew, Nault Isabelle, Miyazaki Shinsuke, Scavee Christophe, Clementy Jacques, Haissaguerre Michel, Jais Pierre. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J. Am. Coll. Cardiol. 2011 Jan 11;57 (2):160–6. doi: 10.1016/j.jacc.2010.05.061. [DOI] [PubMed] [Google Scholar]
  • 10.Berruezo Antonio, Tamborero David, Mont Lluis, Benito Begoña, Tolosana Jose María, Sitges Marta, Vidal Bárbara, Arriagada Germán, Méndez Francisco, Matiello Maria, Molina Irma, Brugada Josep. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur. Heart J. 2007 Apr;28 (7):836–41. doi: 10.1093/eurheartj/ehm027. [DOI] [PubMed] [Google Scholar]
  • 11.Wongcharoen Wanwarang, Tsao Hsuan-Ming, Wu Mei-Han, Tai Ching-Tai, Chang Shih-Lin, Lin Yenn-Jiang, Lo Li-Wei, Chen Yi-Jen, Sheu Ming-Huei, Chang Cheng-Yen, Chen Shih-Ann. Morphologic characteristics of the left atrial appendage, roof, and septum: implications for the ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 2006 Sep;17 (9):951–6. doi: 10.1111/j.1540-8167.2006.00549.x. [DOI] [PubMed] [Google Scholar]
  • 12.Yokokawa Miki, Sundaram Baskaran, Garg Anubhav, Stojanovska Jadranka, Oral Hakan, Morady Fred, Chugh Aman. Impact of mitral isthmus anatomy on the likelihood of achieving linear block in patients undergoing catheter ablation of persistent atrial fibrillation. Heart Rhythm. 2011 Sep;8 (9):1404–10. doi: 10.1016/j.hrthm.2011.04.030. [DOI] [PubMed] [Google Scholar]
  • 13.Oakes Robert S, Badger Troy J, Kholmovski Eugene G, Akoum Nazem, Burgon Nathan S, Fish Eric N, Blauer Joshua J E, Rao Swati N, DiBella Edward V R, Segerson Nathan M, Daccarett Marcos, Windfelder Jessiciah, McGann Christopher J, Parker Dennis, MacLeod Rob S, Marrouche Nassir F. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009 Apr 07;119 (13):1758–67. doi: 10.1161/CIRCULATIONAHA.108.811877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Akoum Nazem, Daccarett Marcos, McGann Chris, Segerson Nathan, Vergara Gaston, Kuppahally Suman, Badger Troy, Burgon Nathan, Haslam Thomas, Kholmovski Eugene, Macleod Rob, Marrouche Nassir. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J. Cardiovasc. Electrophysiol. 2011 Jan;22 (1):16–22. doi: 10.1111/j.1540-8167.2010.01876.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Matsuo Seiichiro, Lellouche Nicolas, Wright Matthew, Bevilacqua Michela, Knecht Sébastien, Nault Isabelle, Lim Kang-Teng, Arantes Leonardo, O'Neill Mark D, Platonov Pyotr G, Carlson Jonas, Sacher Frederic, Hocini Mélèze, Jaïs Pierre, Haïssaguerre Michel. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J. Am. Coll. Cardiol. 2009 Aug 25;54 (9):788–95. doi: 10.1016/j.jacc.2009.01.081. [DOI] [PubMed] [Google Scholar]
  • 16.Drewitz Imke, Willems Stephan, Salukhe Tushar V, Steven Daniel, Hoffmann Boris A, Servatius Helge, Bock Karsten, Aydin Muhammet Ali, Wegscheider Karl, Meinertz Thomas, Rostock Thomas. Atrial fibrillation cycle length is a sole independent predictor of a substrate for consecutive arrhythmias in patients with persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2010 Aug;3 (4):351–60. doi: 10.1161/CIRCEP.110.945279. [DOI] [PubMed] [Google Scholar]
  • 17.Yoshida Kentaro, Ulfarsson Magnus, Oral Hakan, Crawford Thomas, Good Eric, Jongnarangsin Krit, Bogun Frank, Pelosi Frank, Jalife Jose, Morady Fred, Chugh Aman. Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm. 2011 Feb;8 (2):181–7. doi: 10.1016/j.hrthm.2010.10.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hof Irene, Arbab-Zadeh Armin, Scherr Daniel, Chilukuri Karuna, Dalal Darshan, Abraham Theodore, Lima Joao, Calkins Hugh. Correlation of left atrial diameter by echocardiography and left atrial volume by computed tomography. J. Cardiovasc. Electrophysiol. 2009 Feb;20 (2):159–63. doi: 10.1111/j.1540-8167.2008.01310.x. [DOI] [PubMed] [Google Scholar]
  • 19.Verma Atul, Wazni Oussama M, Marrouche Nassir F, Martin David O, Kilicaslan Fethi, Minor Stephen, Schweikert Robert A, Saliba Walid, Cummings Jennifer, Burkhardt J David, Bhargava Mandeep, Belden William A, Abdul-Karim Ahmad, Natale Andrea. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J. Am. Coll. Cardiol. 2005 Jan 18;45 (2):285–92. doi: 10.1016/j.jacc.2004.10.035. [DOI] [PubMed] [Google Scholar]
  • 20.Yoshida Kentaro, Chugh Aman, Good Eric, Crawford Thomas, Myles James, Veerareddy Srikar, Billakanty Sreedhar, Wong Wai S, Ebinger Matthew, Pelosi Frank, Jongnarangsin Krit, Bogun Frank, Morady Fred, Oral Hakan. A critical decrease in dominant frequency and clinical outcome after catheter ablation of persistent atrial fibrillation. Heart Rhythm. 2010 Mar;7 (3):295–302. doi: 10.1016/j.hrthm.2009.11.024. [DOI] [PubMed] [Google Scholar]
  • 21.Chae Sanders, Oral Hakan, Good Eric, Dey Sujoya, Wimmer Alan, Crawford Thomas, Wells Darryl, Sarrazin Jean-Francois, Chalfoun Nagib, Kuhne Michael, Fortino Jackie, Huether Elizabeth, Lemerand Tammy, Pelosi Frank, Bogun Frank, Morady Fred, Chugh Aman. Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence. J. Am. Coll. Cardiol. 2007 Oct 30;50 (18):1781–7. doi: 10.1016/j.jacc.2007.07.044. [DOI] [PubMed] [Google Scholar]
  • 22.Knecht Sébastien, Hocini Mélèze, Wright Matthew, Lellouche Nicolas, O'Neill Mark D, Matsuo Seiichiro, Nault Isabelle, Chauhan Vijay S, Makati Kevin J, Bevilacqua Michela, Lim Kang-Teng, Sacher Frederic, Deplagne Antoine, Derval Nicolas, Bordachar Pierre, Jaïs Pierre, Clémenty Jacques, Haïssaguerre Michel. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur. Heart J. 2008 Oct;29 (19):2359–66. doi: 10.1093/eurheartj/ehn302. [DOI] [PubMed] [Google Scholar]
  • 23.Kistler Peter M, Sanders Prashanthan, Fynn Simon P, Stevenson Irene H, Spence Steven J, Vohra Jitendra K, Sparks Paul B, Kalman Jonathan M. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J. Am. Coll. Cardiol. 2004 Jul 07;44 (1):109–16. doi: 10.1016/j.jacc.2004.03.044. [DOI] [PubMed] [Google Scholar]
  • 24.Roberts-Thomson Kurt C, Kistler Peter M, Sanders Prashanthan, Morton Joseph B, Haqqani Haris M, Stevenson Irene, Vohra Jitendra K, Sparks Paul B, Kalman Jonathan M. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm. 2009 May;6 (5):587–91. doi: 10.1016/j.hrthm.2009.02.023. [DOI] [PubMed] [Google Scholar]
  • 25.Anyukhovsky Evgeny P, Sosunov Eugene A, Chandra Parag, Rosen Tove S, Boyden Penelope A, Danilo Peter, Rosen Michael R. Age-associated changes in electrophysiologic remodeling: a potential contributor to initiation of atrial fibrillation. Cardiovasc. Res. 2005 May 01;66 (2):353–63. doi: 10.1016/j.cardiores.2004.10.033. [DOI] [PubMed] [Google Scholar]
  • 26.Tuan Ta-Chuan, Chang Shih-Lin, Tsao Hsuan-Ming, Tai Ching-Tai, Lin Yenn-Jiang, Hu Yu-Feng, Lo Li-Wei, Udyavar Ameya R, Chang Chien-Jong, Tsai Wen-Chin, Tang Wei-Hua, Suenari Kazuyoshi, Huang Shih-Yu, Lee Pi-Change, Chen Shih-Ann. The impact of age on the electroanatomical characteristics and outcome of catheter ablation in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 2010 Sep;21 (9):966–72. doi: 10.1111/j.1540-8167.2010.01755.x. [DOI] [PubMed] [Google Scholar]
  • 27.Vaquero Miguel, Calvo David, Jalife José. Cardiac fibrillation: from ion channels to rotors in the human heart. Heart Rhythm. 2008 Jun;5 (6):872–9. doi: 10.1016/j.hrthm.2008.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yokokawa Miki, Latchamsetty Rakesh, Good Eric, Crawford Thomas, Jongnarangsin Krit, Pelosi Frank, Bogun Frank, Oral Hakan, Morady Fred, Chugh Aman. The impact of age on the atrial substrate: insights from patients with a low scar burden undergoing catheter ablation of persistent atrial fibrillation. J Interv Card Electrophysiol. 2012 Sep;34 (3):287–94. doi: 10.1007/s10840-011-9657-y. [DOI] [PubMed] [Google Scholar]
  • 29.Bhargava Mandeep, Marrouche Nassir F, Martin David O, Schweikert Robert A, Saliba Walid, Saad Eduardo B, Bash Dianna, Williams-Andrews Michelle, Rossillo Antonio, Erciyes Demet, Khaykin Yaariv, Burkhardt J David, Joseph George, Tchou Patrick J, Natale Andrea. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter:. J. Cardiovasc. Electrophysiol. 2004 Jan;15 (1):8–13. doi: 10.1046/j.1540-8167.2004.03266.x. [DOI] [PubMed] [Google Scholar]
  • 30.Zado Erica, Callans David J, Riley Michael, Hutchinson Mathew, Garcia Fermin, Bala Rupa, Lin David, Cooper Joshua, Verdino Ralph, Russo Andrea M, Dixit Sanjay, Gerstenfeld Edward, Marchlinski Francis E. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J. Cardiovasc. Electrophysiol. 2008 Jun;19 (6):621–6. doi: 10.1111/j.1540-8167.2008.01183.x. [DOI] [PubMed] [Google Scholar]
  • 31.Haegeli Laurent M, Duru Firat. Atrial fibrillation in the aging heart: pharmacological therapy and catheter ablation in the elderly. Future Cardiol. 2011 May;7 (3):415–23. doi: 10.2217/fca.11.22. [DOI] [PubMed] [Google Scholar]
  • 32.Grubitzsch Herko, Grabow Christian, Orawa Helmut, Konertz Wolfgang. Factors predicting the time until atrial fibrillation recurrence after concomitant left atrial ablation. Eur J Cardiothorac Surg. 2008 Jul;34 (1):67–72. doi: 10.1016/j.ejcts.2008.03.054. [DOI] [PubMed] [Google Scholar]
  • 33.Takahashi Yoshihide, Takahashi Atsushi, Kuwahara Taishi, Fujino Tadashi, Okubo Kenji, Kusa Shigeki, Fujii Akira, Yagishita Atsuhiko, Miyazaki Shinsuke, Nozato Toshihiro, Hikita Hiroyuki, Hirao Kenzo, Isobe Mitsuaki. Clinical characteristics of patients with persistent atrial fibrillation successfully treated by left atrial ablation. Circ Arrhythm Electrophysiol. 2010 Oct;3 (5):465–71. doi: 10.1161/CIRCEP.110.949297. [DOI] [PubMed] [Google Scholar]
  • 34.Seow Swee-Chong, Lim Toon-Wei, Koay Choon-Hiang, Ross David L, Thomas Stuart P. Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent atrial fibrillation. Europace. 2007 Dec;9 (12):1129–33. doi: 10.1093/europace/eum219. [DOI] [PubMed] [Google Scholar]
  • 35.Oral Hakan, Chugh Aman, Good Eric, Crawford Thomas, Sarrazin Jean F, Kuhne Michael, Chalfoun Nagib, Wells Darryl, Boonyapisit Warangkna, Gadeela Nitesh, Sankaran Sundar, Kfahagi Ayman, Jongnarangsin Krit, Pelosi Frank, Bogun Frank, Morady Fred. Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2008 Apr;1 (1):6–13. doi: 10.1161/CIRCEP.107.748780. [DOI] [PubMed] [Google Scholar]
  • 36.Weerasooriya Rukshen, Khairy Paul, Litalien Jean, Macle Laurent, Hocini Meleze, Sacher Frederic, Lellouche Nicolas, Knecht Sebastien, Wright Matthew, Nault Isabelle, Miyazaki Shinsuke, Scavee Christophe, Clementy Jacques, Haissaguerre Michel, Jais Pierre. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J. Am. Coll. Cardiol. 2011 Jan 11;57 (2):160–6. doi: 10.1016/j.jacc.2010.05.061. [DOI] [PubMed] [Google Scholar]
  • 37.Miyazaki Shinsuke, Kuwahara Taishi, Kobori Atsushi, Takahashi Yoshihide, Takei Asumi, Sato Akira, Isobe Mitsuaki, Takahashi Atsushi. Catheter ablation of atrial fibrillation in patients with valvular heart disease: long-term follow-up results. J. Cardiovasc. Electrophysiol. 2010 Nov;21 (11):1193–8. doi: 10.1111/j.1540-8167.2010.01812.x. [DOI] [PubMed] [Google Scholar]
  • 38.Di Donna Paolo, Olivotto Iacopo, Delcrè Sara Dalila Luisella, Caponi Domenico, Scaglione Marco, Nault Isabelle, Montefusco Antonio, Girolami Francesca, Cecchi Franco, Haissaguerre Michel, Gaita Fiorenzo. Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. Europace. 2010 Mar;12 (3):347–55. doi: 10.1093/europace/euq013. [DOI] [PubMed] [Google Scholar]
  • 39.Winkle Roger A, Mead R Hardwin, Engel Gregory, Patrawala Rob A. Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation. Am. Heart J. 2011 Jul;162 (1):193–200. doi: 10.1016/j.ahj.2011.04.013. [DOI] [PubMed] [Google Scholar]
  • 40.Gottdiener J S, Reda D J, Williams D W, Materson B J. Left atrial size in hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J. Am. Coll. Cardiol. 1997 Mar 01;29 (3):651–8. doi: 10.1016/s0735-1097(96)00554-2. [DOI] [PubMed] [Google Scholar]
  • 41.Lauer M S, Anderson K M, Kannel W B, Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA. 1991 Jul 10;266 (2):231–6. [PubMed] [Google Scholar]
  • 42.Parish Daniel. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2005 Apr 27;293 (16) doi: 10.1001/jama.293.16.1974-b. [DOI] [PubMed] [Google Scholar]
  • 43.Mohanty Sanghamitra, Mohanty Prasant, Di Biase Luigi, Bai Rong, Pump Agnes, Santangeli Pasquale, Burkhardt David, Gallinghouse Joseph G, Horton Rodney, Sanchez Javier E, Bailey Shane, Zagrodzky Jason, Natale Andrea. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J. Am. Coll. Cardiol. 2012 Apr 03;59 (14):1295–301. doi: 10.1016/j.jacc.2011.11.051. [DOI] [PubMed] [Google Scholar]
  • 44.Patel Dimpi, Mohanty Prasant, Di Biase Luigi, Shaheen Mazen, Lewis William R, Quan Kara, Cummings Jennifer E, Wang Paul, Al-Ahmad Amin, Venkatraman Preeti, Nashawati Eyad, Lakkireddy Dhanunjaya, Schweikert Robert, Horton Rodney, Sanchez Javier, Gallinghouse Joseph, Hao Steven, Beheiry Salwa, Cardinal Deb S, Zagrodzky Jason, Canby Robert, Bailey Shane, Burkhardt J David, Natale Andrea. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol. 2010 Oct;3 (5):445–51. doi: 10.1161/CIRCEP.109.858381. [DOI] [PubMed] [Google Scholar]
  • 45.Benjamin E J, Levy D, Vaziri S M, D'Agostino R B, Belanger A J, Wolf P A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994 Mar 16;271 (11):840–4. [PubMed] [Google Scholar]
  • 46.Yamazaki Masatoshi, Vaquero Luis M, Hou Luqia, Campbell Katherine, Zlochiver Sharon, Klos Matthew, Mironov Sergey, Berenfeld Omer, Honjo Haruo, Kodama Itsuo, Jalife José, Kalifa Jérôme. Mechanisms of stretch-induced atrial fibrillation in the presence and the absence of adrenocholinergic stimulation: interplay between rotors and focal discharges. Heart Rhythm. 2009 Jul;6 (7):1009–17. doi: 10.1016/j.hrthm.2009.03.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.O'Neill Mark D, Wright Matthew, Knecht Sébastien, Jaïs Pierre, Hocini Mélèze, Takahashi Yoshihide, Jönsson Anders, Sacher Frédéric, Matsuo Seiichiro, Lim Kang Teng, Arantes Leonardo, Derval Nicolas, Lellouche Nicholas, Nault Isabelle, Bordachar Pierre, Clémenty Jacques, Haïssaguerre Michel. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur. Heart J. 2009 May;30 (9):1105–12. doi: 10.1093/eurheartj/ehp063. [DOI] [PubMed] [Google Scholar]
  • 48.Haïssaguerre Michel, Hocini Mélèze, Sanders Prashanthan, Sacher Frederic, Rotter Martin, Takahashi Yoshihide, Rostock Thomas, Hsu Li-Fern, Bordachar Pierre, Reuter Sylvain, Roudaut Raymond, Clémenty Jacques, Jaïs Pierre. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J. Cardiovasc. Electrophysiol. 2005 Nov;16 (11):1138–47. doi: 10.1111/j.1540-8167.2005.00308.x. [DOI] [PubMed] [Google Scholar]
  • 49.Rostock Thomas, Steven Daniel, Hoffmann Boris, Servatius Helge, Drewitz Imke, Sydow Karsten, Müllerleile Kai, Ventura Rodolfo, Wegscheider Karl, Meinertz Thomas, Willems Stephan. Chronic atrial fibrillation is a biatrial arrhythmia: data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach. Circ Arrhythm Electrophysiol. 2008 Dec;1 (5):344–53. doi: 10.1161/CIRCEP.108.772392. [DOI] [PubMed] [Google Scholar]
  • 50.Haïssaguerre Michel, Sanders Prashanthan, Hocini Mélèze, Hsu Li-Fern, Shah Dipen C, Scavée Christophe, Takahashi Yoshihide, Rotter Martin, Pasquié Jean-Luc, Garrigue Stéphane, Clémenty Jacques, Jaïs Pierre. Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation. 2004 Jun 22;109 (24):3007–13. doi: 10.1161/01.CIR.0000130645.95357.97. [DOI] [PubMed] [Google Scholar]
  • 51.Oral Hakan, Chugh Aman, Good Eric, Wimmer Alan, Dey Sujoya, Gadeela Nitesh, Sankaran Sundar, Crawford Thomas, Sarrazin Jean F, Kuhne Michael, Chalfoun Nagib, Wells Darryl, Frederick Melissa, Fortino Jackie, Benloucif-Moore Suzanne, Jongnarangsin Krit, Pelosi Frank, Bogun Frank, Morady Fred. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation. 2007 May 22;115 (20):2606–12. doi: 10.1161/CIRCULATIONAHA.107.691386. [DOI] [PubMed] [Google Scholar]
  • 52.Dixit Sanjay, Marchlinski Francis E, Lin David, Callans David J, Bala Rupa, Riley Michael P, Garcia Fermin C, Hutchinson Mathew D, Ratcliffe Sarah J, Cooper Joshua M, Verdino Ralph J, Patel Vickas V, Zado Erica S, Cash Nancy R, Killian Tony, Tomson Todd T, Gerstenfeld Edward P. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012 Apr;5 (2):287–94. doi: 10.1161/CIRCEP.111.966226. [DOI] [PubMed] [Google Scholar]
  • 53.Ho S Y, Sanchez-Quintana D, Cabrera J A, Anderson R H. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 1999 Nov;10 (11):1525–33. doi: 10.1111/j.1540-8167.1999.tb00211.x. [DOI] [PubMed] [Google Scholar]
  • 54.Mansour Moussa, Forleo Giovanni B, Pappalardo Augusto, Barrett Conor, Heist E Kevin, Avella Andrea, Bencardino Gianluigi, Dello Russo Antonio, Casella Michela, Ruskin Jeremy N, Tondo Claudio. Combined use of cryoballoon and focal open-irrigation radiofrequency ablation for treatment of persistent atrial fibrillation: results from a pilot study. Heart Rhythm. 2010 Apr;7 (4):452–8. doi: 10.1016/j.hrthm.2009.12.012. [DOI] [PubMed] [Google Scholar]
  • 55.Oral Hakan, Chugh Aman, Yoshida Kentaro, Sarrazin Jean F, Kuhne Michael, Crawford Thomas, Chalfoun Nagib, Wells Darryl, Boonyapisit Warangkna, Veerareddy Srikar, Billakanty Sreedhar, Wong Wai S, Good Eric, Jongnarangsin Krit, Pelosi Frank, Bogun Frank, Morady Fred. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J. Am. Coll. Cardiol. 2009 Mar 03;53 (9):782–9. doi: 10.1016/j.jacc.2008.10.054. [DOI] [PubMed] [Google Scholar]
  • 56.Nademanee Koonlawee, McKenzie John, Kosar Erol, Schwab Mark, Sunsaneewitayakul Buncha, Vasavakul Thaveekiat, Khunnawat Chotikorn, Ngarmukos Tachapong. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol. 2004 Jun 02;43 (11):2044–53. doi: 10.1016/j.jacc.2003.12.054. [DOI] [PubMed] [Google Scholar]
  • 57.Oral Hakan, Chugh Aman, Good Eric, Wimmer Alan, Dey Sujoya, Gadeela Nitesh, Sankaran Sundar, Crawford Thomas, Sarrazin Jean F, Kuhne Michael, Chalfoun Nagib, Wells Darryl, Frederick Melissa, Fortino Jackie, Benloucif-Moore Suzanne, Jongnarangsin Krit, Pelosi Frank, Bogun Frank, Morady Fred. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation. 2007 May 22;115 (20):2606–12. doi: 10.1161/CIRCULATIONAHA.107.691386. [DOI] [PubMed] [Google Scholar]
  • 58.Hunter Ross J, Diab Ihab, Tayebjee Muzahir, Richmond Laura, Sporton Simon, Earley Mark J, Schilling Richard J. Characterization of fractionated atrial electrograms critical for maintenance of atrial fibrillation: a randomized, controlled trial of ablation strategies (the CFAE AF trial). Circ Arrhythm Electrophysiol. 2011 Oct;4 (5):622–9. doi: 10.1161/CIRCEP.111.962928. [DOI] [PubMed] [Google Scholar]
  • 59.Jaïs Pierre, Matsuo Seiichiro, Knecht Sebastien, Weerasooriya Rukshen, Hocini Mélèze, Sacher Fréderic, Wright Matthew, Nault Isabelle, Lellouche Nicolas, Klein George, Clémenty Jacques, Haïssaguerre Michel. A deductive mapping strategy for atrial tachycardia following atrial fibrillation ablation: importance of localized reentry. J. Cardiovasc. Electrophysiol. 2009 May;20 (5):480–91. doi: 10.1111/j.1540-8167.2008.01373.x. [DOI] [PubMed] [Google Scholar]
  • 60.Hayward Robert M, Upadhyay Gaurav A, Mela Theofanie, Ellinor Patrick T, Barrett Conor D, Heist E Kevin, Verma Atul, Choudhry Niteesh K, Singh Jagmeet P. Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis. Heart Rhythm. 2011 Jul;8 (7):994–1000. doi: 10.1016/j.hrthm.2011.02.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Jaïs Pierre, Hocini Mélèze, Hsu Li-Fern, Sanders Prashanthan, Scavee Christophe, Weerasooriya Rukshen, Macle Laurent, Raybaud Florence, Garrigue Stéphane, Shah Dipen C, Le Metayer Philippe, Clémenty Jacques, Haïssaguerre Michel. Technique and results of linear ablation at the mitral isthmus. Circulation. 2004 Nov 09;110 (19):2996–3002. doi: 10.1161/01.CIR.0000146917.75041.58. [DOI] [PubMed] [Google Scholar]
  • 62.Hocini Mélèze, Jaïs Pierre, Sanders Prashanthan, Takahashi Yoshihide, Rotter Martin, Rostock Thomas, Hsu Li-Fern, Sacher Frédéric, Reuter Sylvain, Clémenty Jacques, Haïssaguerre Michel. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation. 2005 Dec 13;112 (24):3688–96. doi: 10.1161/CIRCULATIONAHA.105.541052. [DOI] [PubMed] [Google Scholar]
  • 63.Li Yi-Gang, Yang Mei, Li Yuhua, Wang Qunshan, Yu Linwei, Sun Jian. Spatial relationship between left atrial roof or superior pulmonary veins and bronchi or pulmonary arteries by dual-source computed tomography: implication for preventing injury of bronchi and pulmonary arteries during atrial fibrillation ablation. Europace. 2011 Jun;13 (6):809–14. doi: 10.1093/europace/eur034. [DOI] [PubMed] [Google Scholar]
  • 64.Yokokawa Miki, Sundaram Baskaran, Oral Hakan, Morady Fred, Chugh Aman. The course of the sinus node artery and its impact on achieving linear block at the left atrial roof in patients with persistent atrial fibrillation. Heart Rhythm. 2012 Sep;9 (9):1395–402. doi: 10.1016/j.hrthm.2012.04.016. [DOI] [PubMed] [Google Scholar]
  • 65.Elayi Claude S, Di Biase Luigi, Barrett Conor, Ching Chi Keong, al Aly Moataz, Lucciola Maria, Bai Rong, Horton Rodney, Fahmy Tamer S, Verma Atul, Khaykin Yaariv, Shah Jignesh, Morales Gustavo, Hongo Richard, Hao Steven, Beheiry Salwa, Arruda Mauricio, Schweikert Robert A, Cummings Jennifer, Burkhardt J David, Wang Paul, Al-Ahmad Amin, Cauchemez Bruno, Gaita Fiorenzo, Natale Andrea. Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation. Heart Rhythm. 2010 Sep;7 (9):1216–23. doi: 10.1016/j.hrthm.2010.01.038. [DOI] [PubMed] [Google Scholar]
  • 66.Estner Heidi L, Hessling Gabriele, Ndrepepa Gjin, Luik Armin, Schmitt Claus, Konietzko Agathe, Ucer Ekrem, Wu JinJin, Kolb Christof, Pflaumer Andreas, Zrenner Bernhard, Deisenhofer Isabel. Acute effects and long-term outcome of pulmonary vein isolation in combination with electrogram-guided substrate ablation for persistent atrial fibrillation. Am. J. Cardiol. 2008 Feb 01;101 (3):332–7. doi: 10.1016/j.amjcard.2007.08.053. [DOI] [PubMed] [Google Scholar]
  • 67.Yoshida Kentaro, Chugh Aman, Ulfarsson Magnus, Good Eric, Kuhne Michael, Crawford Thomas, Sarrazin Jean F, Chalfoun Nagib, Wells Darryl, Boonyapisit Warangkna, Veerareddy Srikar, Billakanty Sreedhar, Wong Wai S, Jongnarangsin Krit, Pelosi Frank, Bogun Frank, Morady Fred, Oral Hakan. Relationship between the spectral characteristics of atrial fibrillation and atrial tachycardias that occur after catheter ablation of atrial fibrillation. Heart Rhythm. 2009 Jan;6 (1):11–7. doi: 10.1016/j.hrthm.2008.09.031. [DOI] [PubMed] [Google Scholar]
  • 68.Yokokawa Miki, Chugh Aman, Ulfarsson Magnus, Takaki Hiroshi, Han Li, Yoshida Kentaro, Sugimachi Masaru, Morady Fred, Oral Hakan. Effect of linear ablation on spectral components of atrial fibrillation. Heart Rhythm. 2010 Dec;7 (12):1732–7. doi: 10.1016/j.hrthm.2010.05.040. [DOI] [PubMed] [Google Scholar]
  • 69.Oral Hakan, Knight Bradley P, Ozaydin Mehmet, Tada Hiroshi, Chugh Aman, Hassan Sohail, Scharf Christoph, Lai Steve W K, Greenstein Radmira, Pelosi Frank, Strickberger S Adam, Morady Fred. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. J. Am. Coll. Cardiol. 2002 Jul 03;40 (1):100–4. doi: 10.1016/s0735-1097(02)01939-3. [DOI] [PubMed] [Google Scholar]
  • 70.Koyama Takashi, Tada Hiroshi, Sekiguchi Yukio, Arimoto Takanori, Yamasaki Hiro, Kuroki Kenji, Machino Takeshi, Tajiri Kazuko, Zhu Xu Dong, Kanemoto-Igarashi Miyako, Sugiyasu Aiko, Kuga Keisuke, Nakata Yoshio, Aonuma Kazutaka. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial. J. Am. Coll. Cardiol. 2010 Oct 26;56 (18):1463–72. doi: 10.1016/j.jacc.2010.04.057. [DOI] [PubMed] [Google Scholar]
  • 71.Lellouche Nicolas, Jaïs Pierre, Nault Isabelle, Wright Matthew, Bevilacqua Michela, Knecht Sébastien, Matsuo Seiichiro, Lim Kang-Teng, Sacher Frederic, Deplagne Antoine, Bordachar Pierre, Hocini Mélèze, Haïssaguerre Michel. Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J. Cardiovasc. Electrophysiol. 2008 Jun;19 (6):599–605. doi: 10.1111/j.1540-8167.2008.01188.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Atrial Fibrillation are provided here courtesy of CardioFront, LLC

RESOURCES